A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Refractory to Epirubicin That Showed Marked Decrease in Tumor Markers after Transcatheter Arterial Infusion with Miriplatin

Miriplatin, a cisplatin derivative with a high affinity for iodized ethyl esters of fatty acids from poppy seed oil, is a novel chemotherapeutic agent designed for use in the transarterial treatment of hepatocellular carcinoma (HCC). Here, we describe transcatheter arterial infusion (TAI) using miri...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Hiroki, Inuzuka, Tadashi, Takeda, Haruhiko, Nakajima, Jun, Sakamoto, Azusa, Henmi, Sinichiro, Ishikawa, Tetsurou, Saito, Sumio, Kita, Ryuichi, Kimura, Toru, Osaki, Yukio, Koshikawa, Yorimitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Published: June 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130984/
https://www.ncbi.nlm.nih.gov/pubmed/21738504
http://dx.doi.org/10.1159/000330106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130984/
https://www.ncbi.nlm.nih.gov/pubmed/21738504
http://dx.doi.org/10.1159/000330106

Ejemplares similares